BOSTON–(BUSINESS WIRE)–$KRTX–Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced the pricing of its upsized initial public […]

IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE:MCK) offers the below statement on today’s Change Healthcare initial public offering: Change Healthcare, Inc., a scaled healthcare information technology company, began trading on the Nasdaq […]

WALTHAM, Mass.–(BUSINESS WIRE)–Morphic Holding, Inc. (“Morphic”), a biopharmaceutical company discovering and developing oral small-molecule integrin therapeutics, today announced the pricing of its upsized initial public offering of 6,000,000 shares of […]

NASHVILLE, Tenn.–(BUSINESS WIRE)–Change Healthcare Inc. (“Change” or “the Company”), a leading independent healthcare technology platform, announced today the pricing of its initial public offering of 42,857,142 shares of its common […]

There is no excerpt because this is a protected post.

In an interview with TD Ameritrade Network,  IPO Edge Editor in Chief John Jannarone explains that highflying tech IPOs such as Zoom (ticker: ZM) and Slack (ticker: WORK) offer great […]

By John Jannarone What’s virtually immune to the economy, technological change, and the Amazon effect? The need to get children out of the house every now and then. Perhaps the […]

MENLO PARK, Calif.–(BUSINESS WIRE)–#personalis–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the closing of its initial public offering of 9,109,725 shares of common stock at […]

In an interview with Cheddar TV, IPO Edge Editor-in-Chief John Jannarone argues that workplace messenger service Slack should find support in coming days thanks to a limited number of likely sellers and a business […]

BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company that is pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today […]